News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
ANI Pharmaceuticals Launches Carbamazepine Extended-Release Capsules
Tuesday, April 14, 2026ANI Pharmaceuticals Inc has announced the launch of Carbamazepine ExtendedRelease Capsules in strengths of mg mg and mg The product is a generic version of Carbatrol
Kymera Therapeutics Receives FDA Fast Track Status for KT-621 in Asthma Treatment
Tuesday, April 14, 2026Kymera Therapeutics Inc has received Fast Track designation from the US Food and Drug Administration for KT an oral STAT degrader developed to treat moderate to severe eosinophilic asthma
OXB Introduces Fast-Track Offering to Speed Up Viral Vector Development and Manufacture
Tuesday, April 14, 2026OXB has launched a new fasttrack development and manufacturing service to support programmes using adenoassociated viral AAV and lentiviral LV vectors The offering is designed to provide a quicker route to GMP manufacturing for eligible biotech clien...
Septerna Begins Phase 1 Trial of Oral SEP-479 for Hypoparathyroidism
Tuesday, April 14, 2026Septerna Inc has started a Phase clinical trial of SEP an oral small molecule designed to treat hypoparathyroidism The company has dosed the first participants in the study
Drug Manufacturing Deals Shift to Europe Amid US Decline and Pharma Tariffs
Monday, April 13, 2026Europe has outpaced the US by more than threefold in contract manufacturing deals for FDAapproved drugs in marking a significant shift in the global pharma manufacturing landscape
EU 2026 Pharma Package Finalized: New Regulatory Framework Reshapes Exclusivity and Innovation Incentives
Friday, April 10, 2026The EU Council has released the final texts of the Pharma Package introducing a flexible exclusivity model and new vouchers for antimicrobials amid ongoing legislative steps
Axplora Invests €30 Million to Boost Lyophilization Capacity at Le Mans Facility
Thursday, April 09, 2026Axplora announces a million investment to enhance lyophilization capabilities at its Le Mans manufacturing facility strengthening European pharma production capacity
Nxera Pharma Reaches Second Development Milestone in Eli Lilly Collaboration for Metabolic Diseases
Thursday, April 09, 2026Nxera Pharma Co Ltd has reached a second development milestone under its multitarget collaboration and licence agreement with Eli Lilly and Company focused on diabetes and metabolic diseases
Alloy Therapeutics Partners with Biogen on Multi-Target ASO Platform Collaboration
Wednesday, April 08, 2026Alloy Therapeutics Inc has entered into a collaboration and licence agreement with Biogen Inc to support the development of antisense therapeutics using its proprietary AntiClastic ASO platform
EU Council Publishes Final 2026 Pharma Package: New Regulatory Framework for Medicinal Products
Wednesday, April 08, 2026The EU Council has released the final texts of the comprehensive Pharma Package introducing flexible data protection periods orphan drug incentives and antimicrobial vouchers to boost innovation and access
